XU Zhi-Ru1, XIAO Lin1, LIAO Jian-Wei2, DAI Chang-Liang2, QIN Yan1*
2012, 43(5): 363-367.
The validated LC-MS and HPLC method were developed for the determination of epothilone B in rat plasma and tissue, respectively. The pharmacokinetic properties of epothilone B were examined after a single iv injection of 0.5, 1 and 2 mg/kg to rats, respectively. The results suggested that the pharmacokinetic properties of epothilone B fitted well into a two-compartment open model with t1/2β of (7.17±0.68), (7.65±1.40) and (6.68±0.36)h, and AUC0→t of (60.4±6.5), (160.4±37.8) and (428.8±67.1)ng·ml-1·h according to the single dose of 0.5, 1 and 2 mg/kg, respectively. A single dose (1 mg/ml) of epothilone B to tumor bearing Wistar rats resulted in a very rapid wide distribution from plasma to tissue. Plasma elimination was very rapid, while the elimination in tumor was rather slow.